In the present study, the pharmacological interventions for AD were based on thethree available cholin-esterase inhibitors: Rivastigmine, Galantamine and Donepezil.In the FC Group, 44% of patients used Riv-astigmine, 44% Galantamine and 11%Donepezil. Here, BCHE is linked to Alzheimer disease.